BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2577327)

  • 1. Treatment of murine lymphoma with anti-Thy-1.1 antibodies.
    Badger CC; Bernstein ID
    Immunol Ser; 1989; 45():515-29. PubMed ID: 2577327
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of antibody isotype on passive serotherapy of lymphoma.
    Denkers EY; Badger CC; Ledbetter JA; Bernstein ID
    J Immunol; 1985 Sep; 135(3):2183-6. PubMed ID: 2862210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental radiotherapy of murine lymphoma with 131I-labeled anti-Thy 1.1 monoclonal antibody.
    Badger CC; Krohn KA; Peterson AV; Shulman H; Bernstein ID
    Cancer Res; 1985 Apr; 45(4):1536-44. PubMed ID: 3978621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.
    Ramakrishnan S; Houston LL
    Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to nonpolymorphic determinants of the Thy-1 molecule inhibit T cell proliferation.
    Hollander N
    J Immunol; 1985 May; 134(5):2916-21. PubMed ID: 2858507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo.
    Thorpe PE; Brown AN; Bremner JA; Foxwell BM; Stirpe F
    J Natl Cancer Inst; 1985 Jul; 75(1):151-9. PubMed ID: 3859688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental radioimmunotherapy of murine lymphoma with 131I-labeled anti-T-cell antibodies.
    Badger CC; Krohn KA; Shulman H; Flournoy N; Bernstein ID
    Cancer Res; 1986 Dec; 46(12 Pt 1):6223-8. PubMed ID: 3779642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody therapy of spontaneous AKR T-cell leukemia.
    Badger CC; Shulman H; Peterson AV; Bernstein ID
    Cancer Res; 1986 Aug; 46(8):4058-63. PubMed ID: 2873885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-specific cytotoxicity expressed by a conjugate of ricin and murine monoclonal antibody directed against thy 1.1 antigen.
    Houston LL; Nowinski RC
    Cancer Res; 1981 Oct; 41(10):3913-7. PubMed ID: 6116537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two anti-Thy 1.1-abrin A-chain immunotoxins prepared with different cross-linking agents: antitumor effects, in vivo fate, and tumor cell mutants.
    Thorpe PE; Blakey DC; Brown AN; Knowles PP; Knyba RE; Wallace PM; Watson GJ; Wawrzynczak EJ
    J Natl Cancer Inst; 1987 Nov; 79(5):1101-12. PubMed ID: 2890786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Thy-1 antibody responses evoked by Thy-1 antigen expressed in transfected mouse mastocytoma cells and rat fibroblast.
    Isobe K; Fortunato A; Giguere V; Grosveld F; Mitchison NA
    Immunology; 1985 Nov; 56(3):505-12. PubMed ID: 2867029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antilymphocytic antibodies and marrow transplantation. VII. Two of nine monoclonal anti-Thy-1 antibodies used for pretreatment of donor marrow suppressed graft-versus-host reactions without added complement.
    Thierfelder S; Cobbold S; Kummer U; Waldmann H; Schuh R
    Exp Hematol; 1985 Oct; 13(9):948-55. PubMed ID: 2864278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of alteration of murine Ir-Thy-1 gene product on anti-Thy-1 response.
    Quackenbush LJ; Gorzynski TJ; Dowjat WK; Zaleski MB
    Transplant Proc; 1987 Feb; 19(1 Pt 1):880-2. PubMed ID: 2908555
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-Thy-1 in bone marrow transplantation.
    Thierfelder S; Kummer U; Hoffmann-Fezer G
    Immunol Ser; 1989; 45():531-72. PubMed ID: 2577328
    [No Abstract]   [Full Text] [Related]  

  • 15. Cellular mechanism of primary anti-Thy-1 antibody responses in vitro induced by uniquely immunogenic thymocyte antigens.
    Isobe KI; Nakashima I; Nagase F; Kato N; Mizoguchi K; Kawashima K; Lake P
    J Immunol; 1984 Mar; 132(3):1100-5. PubMed ID: 6141204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic drift and clonal variation in differentiation antigen expression on AKR T-cell lymphoma lines grown in vitro.
    Howell AL; Richie ER
    Nat Immun Cell Growth Regul; 1983-1984; 3(3):143-54. PubMed ID: 6150437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of autoimmune MRL/Ipr mice with monoclonal antibody to Thy-1.2: a single injection has sustained effects on lymphoproliferation and renal disease.
    Seaman WE; Wofsy D; Greenspan JS; Ledbetter JA
    J Immunol; 1983 Apr; 130(4):1713-8. PubMed ID: 6187819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal IgG3 (kappa) antibodies against murine Thy-1.2 antigen produced by murine hybridomas. Differences in the specificity of the antigen binding site and in the structure of the hinge region.
    Zikán J; Dráber P; Vojtísková M
    Folia Biol (Praha); 1982; 28(6):377-94. PubMed ID: 6186535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the selective cytotoxic effects of immunotoxins containing ricin A chain or pokeweed antiviral protein and anti-Thy 1.1 monoclonal antibodies.
    Ramakrishnan S; Houston LL
    Cancer Res; 1984 Jan; 44(1):201-8. PubMed ID: 6140077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-mediated lysis of tumor targets directed by murine monoclonal antibodies of IgM and all IgG isotypes.
    Ralph P; Nakoinz I
    J Immunol; 1983 Aug; 131(2):1028-31. PubMed ID: 6134771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.